Imatib®
Imatinib
Therapeutic action
Antineoplastic. Tyrosine kinase inhibitor
Indications
Philadelphia chromosome-positive acute lymphoblastic leukemia / Chronic myeloid leukemia / Mastocytosis / SMD-SMP / SHE-LEC / GIST / Dermatofibrosarcoma protuberans
Presentation
Coated tablets of 100 mg and 400 mg